Covid-19 India Updates: Over 1,000 Dead In A Day; Zydus Cadila Seeks Vaccine Nod
- Author: BQ Desk
- Science
-
Jul 01, 2021 10:31 am IST
-
Published On Jul 01, 2021 10:31 am IST
-
Last Updated On Jul 01, 2021 10:31 am IST
-
Zydus Cadila has sought Emergency Use Authorisation from Drug Controller General of India for ZyCoV-D, its Plasmid DNA vaccine for Covid-19, Cadila Healthcare informed the exchanges on Thursday.
Interim results from Phase III clinical trials show primary efficacy of 66.6%, according to the statement. "No moderate case of Covid-19 disease was observed post administration of the third dose... No severe cases or deaths due to Covid-19 occurred after administration of the second dose."
The study carried out in more than 50 clinical sites spread across the country during the peak of second wave reaffirms the vaccine’s efficacy against new mutant strains especially the delta variant, the company added.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.